Cargando…
Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder
BACKGROUND: Amino acid neurotransmitters and nitric oxide (NO) are involved in the pathogenesis of major depressive disorder (MDD). Here we want to establish whether changes in their plasma levels may serve as biomarker for the melancholic subtype of this disorder. METHODS: Plasma levels of glutamic...
Autores principales: | Lu, Yun-Rong, Fu, Xin-Yan, Shi, Li-Gen, Jiang, Yan, Wu, Juan-Li, Weng, Xiao-Juan, Wang, Zhao-Pin, Wu, Xue-Yan, Lin, Zheng, Liu, Wei-Bo, Li, Hui-Chun, Luo, Jian-Hong, Bao, Ai-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036745/ https://www.ncbi.nlm.nih.gov/pubmed/24767108 http://dx.doi.org/10.1186/1471-244X-14-123 |
Ejemplares similares
-
Disrupted Regional Homogeneity in Melancholic and Non-melancholic Major Depressive Disorder at Rest
por: Yan, Meiqi, et al.
Publicado: (2021) -
Differentiating Melancholic and Non-melancholic Major Depressive Disorder Using Fractional Amplitude of Low-Frequency Fluctuations
por: Zhang, Yingying, et al.
Publicado: (2022) -
A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022) -
Comparison of short-term (saliva) and long-term (hair) cortisol levels in out-patients with melancholic and non-melancholic major depression
por: Herane-Vives, Andrés, et al.
Publicado: (2020) -
A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
por: Wang, Yun, et al.
Publicado: (2021)